Skip to main content
. 2024 Jan 1;21(3):474–482. doi: 10.7150/ijms.90145

Table 5.

Association between GKN1 polymorphism rs4254535 in dominant genotype and prognosis of Chinese patients with lung cancer.

Variables Death/survive HR (95% CI) P HR* (95% CI) P*
T/T (ref) T/C + C/C
Sex
Female 92/37 74/26 0.95 (0.70-1.29) 0.731 0.93 (0.68-1.27) 0.647
Male 254/56 245/52 0.91 (0.76-1.09) 0.297 0.91 (0.77-1.09) 0.314
Age
Age < 60 126/47 104/37 0.93 (0.72-1.21) 0.587 0.92 (0.71-1.20) 0.545
Age >= 60 220/46 215/41 0.93 (0.77-1.12) 0.450 0.94 (0.77-1.13) 0.487
Smoking stage
Nonsmoker 93/39 76/29 - - - -
Smoker 245/51 239/44 0.95 (0.79-1.13) 0.536 0.95 (0.79-1.14) 0.569
Family History
Yes 116/30 128/25 1.14 (0.89-1.47) 0.295 1.14 (0.88-1.47) 0.325
No 230/63 191/53 0.81 (0.67-0.99) 0.036 0.82 (0.68-1.00) 0.046
Stage
Early stage 45/34 31/44 0.68 (0.43-1.08) 0.102 0.68 (0.43-1.08) 0.100
Late stage 275/57 262/28 0.99 (0.84-1.18) 0.931 0.98 (0.83-1.16) 0.817
Subtype
ADC 151/44 124/47 0.78 (0.61-0.98) 0.037 0.78 (0.61-0.99) 0.039
SCC 110/25 128/18 1.07 (0.83-1.38) 0.598 1.05 (0.81-1.36) 0.694
SCLC 32/9 26/4 0.89 (0.53-1.51) 0.671 0.86 (0.50-1.46) 0.574
NSCLC 314/84 293/74 0.93 (0.80-1.09) 0.393 0.93 (0.79-1.09) 0.339

* Adjusted by age, gender. CI, confidence interval; HR, hazard ratio; ref, reference.